Lifeloc Technologies, Inc. (LCTC) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $11.3M is the value of all shares combined. Beta 0.74: the stock has moved about 26% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerLifeloc Technologies, Inc. (LCTC) trades at $4.10 with MoonshotScore 50/100 (Grade B). Lifeloc Technologies, Inc. specializes in developing and manufacturing breathalyzers and related accessories. Market cap: $11.3M, Sector: Technology.
Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for LCTC: LCTC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates LCTC against Technology peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
LCTC: 1/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Lifeloc Technologies, Inc. (LCTC) Technology Profile & Competitive Position
Lifeloc Technologies, Inc. provides breath alcohol testing equipment and related services, targeting law enforcement, workplace safety, and corrections markets. With a focus on fuel-cell-based technology, the company offers a range of portable and fixed-station breathalyzers, accessories, and training programs, operating as a subsidiary of EDCO Partners LLLP.
What Is the Investment Thesis for LCTC?
Lifeloc Technologies, Inc. presents a focused investment opportunity within the breathalyzer market, driven by increasing demand for alcohol detection solutions across law enforcement, workplace safety, and corrections sectors. The company's established product line, including the Phoenix 6.0 and R.A.D.A.R system, provides a foundation for revenue generation. However, the company's negative profit margin of -14.6% and ROE of -21.0% indicate financial challenges that need to be addressed. A potential growth catalyst lies in expanding its online training programs and leveraging its existing real estate assets. Investors should closely monitor Lifeloc's ability to improve profitability and manage its debt-to-equity ratio of 32.64%.
Based on FMP financials and quantitative analysis
LCTC Key Highlights
Market Cap of $11.3M reflects its small size within the technology sector.
- Gross Margin of 39.8% indicates the profitability of its core breathalyzer products and services.
- Debt-to-Equity Ratio of 32.64% suggests a moderate level of financial leverage.
- Negative Profit Margin of -14.6% highlights the need for improved cost management and revenue generation.
- Beta of 0.74 indicates lower volatility compared to the overall market.
Who Are LCTC's Competitors?
What Are LCTC's Key Strengths?
Specialized expertise in fuel-cell breathalyzer technology.
- Established relationships with law enforcement agencies.
- Comprehensive suite of services and training programs.
- Recurring revenue from supplies, accessories, and real estate.
What Are LCTC's Weaknesses?
Small market capitalization and limited financial resources.
- Negative profit margin and return on equity.
- High dependence on specific markets (law enforcement, workplace safety).
- Limited brand recognition compared to larger competitors.
What Could Drive LCTC Stock Higher?
Potential new contracts with law enforcement agencies for breathalyzer supply.
- Expansion of online training programs for drug and alcohol awareness.
- Development and launch of advanced breathalyzer technologies.
- Potential partnerships with international distributors to expand geographic reach.
- Real estate revenue from commercial leases.
What Are the Key Risks for LCTC?
Negative return on equity (-47.6%) — the business is not currently generating profit on shareholder capital.
- Increased competition from larger players in the breathalyzer market.
- Technological advancements rendering existing products obsolete.
- Changes in government regulations affecting alcohol testing requirements.
- Negative profit margin and return on equity impacting financial stability.
- Limited liquidity and price volatility due to OTC listing.
What Are the Growth Opportunities for LCTC?
- Expansion of Online Training Programs: Lifeloc can leverage its expertise to expand its online drug and alcohol training programs, targeting a broader audience and generating recurring revenue streams. The market for online safety training is growing, with increasing demand from employers seeking to comply with regulatory requirements. By offering comprehensive and accessible training solutions, Lifeloc can capitalize on this trend and establish itself as a leading provider of online safety education.
- Penetration of the Workplace Safety Market: The workplace safety market represents a significant growth opportunity for Lifeloc, driven by increasing awareness of the risks associated with alcohol consumption in the workplace. By offering portable and fixed-station breathalyzers, along with related services and training, Lifeloc can help employers create safer work environments and reduce the risk of accidents and injuries. The company can target industries such as construction, transportation, and manufacturing, where alcohol testing is particularly important.
- Geographic Expansion into International Markets: Lifeloc can expand its geographic reach by targeting international markets with strong demand for alcohol detection solutions. Countries with strict drunk driving laws and workplace safety regulations represent attractive opportunities for growth. By establishing partnerships with local distributors and adapting its products to meet local requirements, Lifeloc can successfully penetrate these markets and increase its global market share.
- Development of Advanced Breathalyzer Technologies: Investing in the development of advanced breathalyzer technologies, such as those incorporating biometric authentication or real-time data analytics, can provide Lifeloc with a competitive edge. These technologies can enhance the accuracy, reliability, and usability of its products, making them more attractive to customers. By staying at the forefront of technological innovation, Lifeloc can maintain its position as a leading provider of breath alcohol testing equipment.
- Leveraging Real Estate Assets for Additional Revenue: Lifeloc's ownership and rental of real property through existing commercial leases provides a stable source of revenue. The company can optimize its real estate portfolio by increasing occupancy rates, negotiating favorable lease terms, and exploring opportunities for property development. By effectively managing its real estate assets, Lifeloc can generate additional revenue and improve its overall financial performance.
What Are LCTC's Competitive Advantages?
- Specialized fuel-cell based breathalyzer technology.
- Established presence in the law enforcement and workplace safety markets.
- Comprehensive suite of services and training programs.
- Ownership of real property providing a stable revenue stream.
What Does LCTC Do?
Lifeloc Technologies, Inc., founded in 1983 and headquartered in Wheat Ridge, Colorado, specializes in the development, manufacturing, and marketing of breathalyzers and related accessories. The company's products cater to a diverse range of markets, including law enforcement, workplace safety, corrections, original equipment manufacturing (OEM), and consumer sectors worldwide. Lifeloc's core offerings include portable hand-held and fixed-station breathalyzers that utilize fuel-cell technology for accurate alcohol detection. Beyond the hardware, Lifeloc provides a comprehensive suite of services and products to support alcohol testing programs, including supplies, accessories, services, and training. The company also offers online drug and alcohol training and refresher courses, enhancing its value proposition to customers. In addition to its core business, Lifeloc engages in real estate activities through the ownership and rental of commercial properties. Its product portfolio includes the Sentinel zero tolerance alcohol screening station, R.A.D.A.R (Real-Time Alcohol Detection and Reporting) system, EASYCAL automatic calibration station, Phoenix 6.0 evidential breath testers, and SpinDx. Lifeloc Technologies, Inc. operates as a subsidiary of EDCO Partners LLLP.
What Products and Services Does LCTC Offer?
- Develops portable hand-held breathalyzers.
- Manufactures fixed station breathalyzers.
- Markets breathalyzers to law enforcement agencies.
- Sells breath alcohol testing equipment to workplaces.
- Provides breathalyzers for corrections facilities.
- Offers online drug and alcohol training courses.
- Engages in real property ownership and rental.
How Does LCTC Make Money?
- Sales of portable and fixed-station breathalyzers.
- Recurring revenue from supplies, accessories, and services.
- Subscription fees from online drug and alcohol training courses.
- Rental income from commercial real estate properties.
What Industry Does LCTC Operate In?
Lifeloc Technologies operates within the scientific and technical instruments industry, which is experiencing steady growth driven by increasing demand for safety and security solutions. The market for breathalyzers is competitive, with key players focusing on technological innovation and expanding their product portfolios. Lifeloc's focus on fuel-cell technology and comprehensive service offerings positions it to capture a share of this market. However, the company faces competition from larger, more established players with greater resources and broader market reach.
Who Are LCTC's Key Customers?
- Law enforcement agencies requiring accurate alcohol testing.
- Workplaces implementing alcohol testing programs for safety.
- Corrections facilities monitoring alcohol consumption.
- Original equipment manufacturers (OEMs) integrating breathalyzers into their products.
- Consumers seeking personal alcohol testing devices.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 28 days ago
- ● No analyst coverage
Why 50?
This rating comes from our nine-signal model, which produces a score but not a per-factor breakdown. The sector-relative five-pillar model, which explains its own contributions, does not cover this listing yet. How the score is built →
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 50 |
| 2026-08-26 | 50 |
| 2026-08-29 | 50 |
| 2026-09-01 | 50 |
| 2026-09-04 | 50 |
| 2026-09-07 | 50 |
| 2026-09-10 | 50 |
What changed?
The score has stayed at 50.
Over the same 18 days the stock moved -2.4%.
Company Profile
Lifeloc Technologies, Inc. operates in the Hardware, Equipment & Parts industry within the Technology sector. It is headquartered in Wheat Ridge, US. The company is led by CEO Wayne R. Willkomm. LCTC has traded publicly since 2012.
Lifeloc Technologies, Inc. Financial Trajectory
Lifeloc Technologies, Inc. (LCTC) reported $2.4M in revenue for Q2 FY2026, reflecting 6.6% growth compared to the prior quarter. The company recorded a net loss of $134K, with diluted EPS of $-0.05. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this micro-cap Technology company. Across the four most recent quarters, LCTC averaged $-0.19 in diluted EPS.
How Lifeloc Technologies, Inc. Is Valued
Lifeloc Technologies, Inc. carries a market capitalization of $11.3M, placing it in the micro-cap category.
Key Financial Metrics
Return on equity for Lifeloc Technologies, Inc. stands at -47.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -34.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -1.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 4.11 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -28.5%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Lifeloc Technologies, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.15 places it in the safe zone, indicating low near-term bankruptcy risk.
Insider Activity
Over the past six months, Lifeloc Technologies, Inc. insiders filed 2 SEC Form 4 transactions — 0 sales and 2 purchases. On net that is roughly 1K shares acquired (about $4K) — insiders putting money in tends to read as conviction.
LCTC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Specialized expertise in fuel-cell breathalyzer technology.
- Established relationships with law enforcement agencies.
- Comprehensive suite of services and training programs.
- Recurring revenue from supplies, accessories, and real estate.
Bear Case
- Small market capitalization and limited financial resources.
- Negative profit margin and return on equity.
- High dependence on specific markets (law enforcement, workplace safety).
- Limited brand recognition compared to larger competitors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $2M | -$134,330 | -$0.05 |
| Q1 FY2026 | $2M | -$152,713 | -$0.06 |
| Q4 FY2025 | $2M | -$2M | -$0.55 |
| Q3 FY2025 | $2M | -$263,439 | -$0.10 |
Q2 FY2026 · filed 14 Aug 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
LCTC Latest News
-
Lifeloc Reports Second Quarter 2026 Results
accessnewswire.com · Aug 13, 2026
LCTC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for LCTC.
Price Targets
Wall Street price target analysis for LCTC.
LCTC MoonshotScore
What does this score mean?
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. LCTC scores 50/100 (Grade B): the number comes from the legacy nine-factor engine (quantitative signals from revenue growth to news sentiment), written once, not refreshed.
LCTC OTC Market Information
The OTC Other tier, where Lifeloc Technologies trades, represents the lowest tier of the OTC market. Companies in this tier often have limited financial disclosure and may not meet minimum financial standards. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, resulting in higher information asymmetry and increased risk for investors. This tier is generally reserved for companies that are distressed, in bankruptcy, or unwilling or unable to meet the listing requirements of higher tiers or exchanges.
- OTC Tier: OTC Other
- Limited Financial Disclosure: The lack of readily available financial information increases the risk of investing in LCTC.
- Low Liquidity: The limited trading volume can make it difficult to buy or sell shares at desired prices.
- Price Volatility: OTC stocks are generally more volatile than those listed on major exchanges.
- Regulatory Scrutiny: OTC companies are subject to less regulatory oversight, increasing the potential for fraud or mismanagement.
- Going Concern Risk: Companies trading on the OTC Other tier may face financial distress or bankruptcy risk.
- Verify the availability of audited financial statements.
- Assess the company's management team and their track record.
- Analyze the company's business model and competitive landscape.
- Evaluate the company's debt levels and cash flow.
- Review any legal or regulatory filings related to the company.
- Monitor trading volume and price volatility.
- Consult with a qualified financial advisor.
- Long operating history since incorporation in 1983.
- Presence of established products in the market (e.g., Phoenix 6.0, R.A.D.A.R).
- Partnerships with law enforcement agencies and workplace safety programs.
- Subsidiary status under EDCO Partners LLLP.
- Physical headquarters located in Wheat Ridge, Colorado.
LCTC Technology Stock FAQ
What does the AI Score mean for LCTC?
LCTC holds an AI Score of 50/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. The number comes from the legacy nine-factor engine (quantitative signals from revenue growth to news sentiment), written once, not refreshed. Lifeloc Technologies, Inc. specializes in developing and manufacturing breathalyzers and related accessories.
Is LCTC a good stock?
Stock Expert AI does not rate LCTC buy, sell or hold. Lifeloc Technologies, Inc. carries a MoonshotScore of 50/100 on the legacy nine-factor engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about LCTC stock?
As of 2026-03-16, formal analyst coverage of Lifeloc Technologies, Inc. (LCTC) is limited due to its small market capitalization and OTC listing.
What are the key factors to evaluate for LCTC?
Lifeloc Technologies, Inc. (LCTC) holds a MoonshotScore of 50/100 (moderate). However, the company's negative profit margin of -14.6% and ROE of -21.0% indicate financial challenges that need to be addressed. Not financial advice.
How frequently does LCTC data refresh on this page?
LCTC's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven LCTC's recent stock price performance?
Lifeloc Technologies, Inc. (LCTC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in fuel-cell breathalyzer technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider LCTC overvalued or undervalued right now?
Lifeloc Technologies, Inc. (LCTC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of LCTC?
Yes, most major brokerages offer fractional shares of Lifeloc Technologies, Inc. (LCTC) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track LCTC's earnings and financial reports?
Lifeloc Technologies, Inc. (LCTC) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for LCTC earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-listed companies.
- Financial data based on available public information.